We are live on ! Find out more
PIP

Peachtree Investment Partners Portfolio holdings

AUM $312M
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
-11.74%
1 Year Est. Return
+27.01%
3 Year Est. Return
+92.23%
5 Year Est. Return
+139.64%
10 Year Est. Return
AUM
$160M
AUM Growth
-$57.4M
Cap. Flow
-$29.7M
Cap. Flow %
-18.56%
Top 10 Hldgs %
59.55%
Holding
109
New
8
Increased
23
Reduced
47
Closed
13

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$2.05M
2
LLY icon
Eli Lilly
LLY
+$1.98M
3
HSY icon
Hershey
HSY
+$1.23M
4
BMY icon
Bristol-Myers Squibb
BMY
+$988K
5
MRK icon
Merck
MRK
+$921K

Sector Composition

Rank Sector Weight
1 Technology 34.97%
2 Healthcare 17.15%
3 Financials 12.97%
4 Consumer Discretionary 12.51%
5 Consumer Staples 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYM icon
26
Vanguard High Dividend Yield ETF
VYM
$83.8B
$1.26M 0.79%
12,370
-15,027
-55% -$1.63M
VTI icon
27
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$1.25M 0.78%
6,630
-7,077
-52% -$1.45M
PG icon
28
Procter & Gamble
PG
$338B
$1.21M 0.75%
8,393
+78
+0.9% +$11.7K
SCHB icon
29
Schwab US Broad Market ETF
SCHB
$44.7B
$1.15M 0.72%
77,880
-67,590
-46% -$1.08M
SCHD icon
30
Schwab US Dividend Equity ETF
SCHD
$107B
$1.11M 0.69%
46,326
-4,413
-9% -$112K
LHX icon
31
L3Harris
LHX
$53.3B
$1.07M 0.67%
4,416
+1,468
+50% +$354K
PEP icon
32
PepsiCo
PEP
$189B
$1.03M 0.64%
6,201
-9
-0.1% -$1.51K
MRK icon
33
Merck
MRK
$322B
$947K 0.59%
+10,387
New +$921K
SYK icon
34
Stryker
SYK
$134B
$935K 0.58%
4,699
+27
+0.6% +$6.34K
KO icon
35
Coca-Cola
KO
$372B
$887K 0.55%
14,098
+2,019
+17% +$128K
ABBV icon
36
AbbVie
ABBV
$442B
$719K 0.45%
4,698
-455
-9% -$69.5K
IJH icon
37
iShares Core S&P Mid-Cap ETF
IJH
$127B
$680K 0.42%
15,035
-1,470
-9% -$72.6K
ROST icon
38
Ross Stores
ROST
$80.8B
$642K 0.4%
9,141
-4,635
-34% -$413K
ROL icon
39
Rollins
ROL
$17.8B
$639K 0.4%
18,306
+98
+0.5% +$3.37K
TXN icon
40
Texas Instruments
TXN
$257B
$623K 0.39%
4,054
-4,513
-53% -$759K
LMT icon
41
Lockheed Martin
LMT
$138B
$621K 0.39%
1,444
+6
+0.4% +$2.63K
NSC icon
42
Norfolk Southern
NSC
$75.2B
$621K 0.39%
2,731
-513
-16% -$126K
FHN icon
43
First Horizon
FHN
$12B
$615K 0.38%
28,118
TROW icon
44
T. Rowe Price
TROW
$24.3B
$601K 0.38%
5,294
-190
-3% -$24.1K
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$582K 0.36%
1,542
-6,148
-80% -$2.52M
ED icon
46
Consolidated Edison
ED
$39.8B
$572K 0.36%
6,017
-1,154
-16% -$110K
CSX icon
47
CSX Corp
CSX
$92.5B
$533K 0.33%
18,355
-8,030
-30% -$262K
CMCSA icon
48
Comcast
CMCSA
$91B
$471K 0.29%
12,000
BLK icon
49
Blackrock
BLK
$178B
$467K 0.29%
766
-250
-25% -$163K
CVX icon
50
Chevron
CVX
$386B
$439K 0.27%
3,035
+1,489
+96% +$246K

Similar funds

Peachtree Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Peachtree Investment Partners held 109 positions worth $160M, down 26% from $218M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Peachtree Investment Partners withdrew a net $29.7M in Q2 2022, closing 13 positions and reducing 47 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peachtree Investment Partners opened a new position in Merck worth $947K.

  • Peachtree Investment Partners's largest Q2 2022 buy was Merck: 10,387 shares worth $947K.
  • Peachtree Investment Partners added most to McKesson in Q2 2022, an estimated $2.05M increase.
  • Peachtree Investment Partners's biggest Q2 2022 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.91M.
  • Peachtree Investment Partners fully exited iShares Core S&P 500 ETF in Q2 2022, selling an estimated $1.91M.
  • Peachtree Investment Partners's ten largest holdings make up 60% of its $160M portfolio in Q2 2022.
  • Peachtree Investment Partners opened 8 new positions and closed 13 in Q2 2022.
  • Peachtree Investment Partners's portfolio value fell 26% quarter-over-quarter to $160M.

Based on Peachtree Investment Partners's 13F filing for Q2 2022, filed 16 Aug 2022.